News | March 04, 2022
USFDA refuses to grant EUA to Covaxin for padeatric use
Covaxin is not approved in the USA for any age group
Covaxin is not approved in the USA for any age group
Meteoric Biopharmaceuticals have made rapid strides in the development of enzymes, probiotics and veterinary health products. It is seeking opportunities to scale up its growth backed by cutting edge R&D. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals spoke to Thomas C Thottathil on the way forward
The accelerated growth of Medix Biochemica will establish its status as the ultimate IVD raw materials supplier
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
OmniActive seeks to improve lives by enhancing nutrition and wellness through science and innovation
Large players are adequately capitalised to make bigger investments to adjust for the ongoing fundamental shift in market opportunities
12-week certificate course commences on March 10th 2022
The product will be manufactured at Lupin’s facility in Pithampur, India
The availability of advanced SLED dialysis for critical patients, Plasmapheresis, CRRT machines along with ICCU dialysis complete the centre in every way
Company expects strong organic growth in sales, EBITDA in 2022
Subscribe To Our Newsletter & Stay Updated
